KOREAN
Company
Business
R & D
Investors
Company Overview
Welcome Message
Vision & Mission
History
C.I
Careers
Contact Us
Umbilical Cord Blood-derived Stem Cell
Stem Cell Therapy
Stem Cell Conditioned Media
Stem Cell Culture Media
Cell Freezing and Thawing Platform
CDMO
Health & Beauty(H&B) Business
Core Technology
Global R&D Center
Stem Cell GMP Center
Pipeline
Notice
IR
PR
Investors
Notice
IR
Disclosure Information
Stock Information
IR Resource Center
IR Letter & FAQ
PR
Press Release
PR Resource Center
IR Letter & FAQ
Investors
IR
IR Letter & FAQ
목록으로
유화증권 분석자료
2018.02.08
유화증권 분석자료
작성일자: 2018.01.08
출처: 유화증권 김요한
유화증권_강스템바이오텍_2018.01.08.pdf
목록으로
골든브릿지투자증권 분석자료(2018.02.02)
[IR Letter] 강스템바이오텍 IR Letter_2017년 제 2호
About Us
Stock Information
Careers
Contact Us
Global R&D Center
Stem Cell GMP Center
Pipeline
TOP
board : irletter : view : : /board/irletter/view
유화증권_강스템바이오텍_2018.01.08.pdf
